Drugs / adrenocorticotropic hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03465111 | Jan 2019 → Dec 2024 | anterior scleritis | Metropolitan Eye Research & Surgery Institute | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “ACTH (adrenocorticotropic hormone) gel” NCT03465111 ↗ |
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03465111 ↗ |
| Modality | Peptide | “ACTH is a member of a group of peptide hormones” NCT03465111 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT03465111 ↗ |